Olaplex Holdings, Inc. (NASDAQ:OLPX – Get Free Report) General Counsel John C. Duffy sold 11,730 shares of the company’s stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $1.24, for a total transaction of $14,545.20. Following the completion of the sale, the general counsel now directly owns 668,026 shares of the company’s stock, valued at $828,352.24. The trade was a 1.73 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
Olaplex Stock Performance
Shares of Olaplex stock traded up $0.06 during midday trading on Thursday, hitting $1.22. The company had a trading volume of 946,385 shares, compared to its average volume of 2,213,694. The company has a fifty day simple moving average of $1.35 and a 200 day simple moving average of $1.69. The stock has a market cap of $810.84 million, a price-to-earnings ratio of 20.34 and a beta of 2.39. The company has a quick ratio of 10.32, a current ratio of 11.84 and a debt-to-equity ratio of 0.73. Olaplex Holdings, Inc. has a 12-month low of $1.01 and a 12-month high of $2.77.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on OLPX. Piper Sandler boosted their price objective on shares of Olaplex from $1.50 to $2.00 and gave the stock a “neutral” rating in a research note on Monday, January 6th. Telsey Advisory Group reissued a “market perform” rating and set a $2.00 target price on shares of Olaplex in a research report on Wednesday, March 12th. Finally, Barclays lifted their price target on shares of Olaplex from $1.50 to $1.70 and gave the stock an “equal weight” rating in a report on Wednesday, March 5th.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the stock. T. Rowe Price Investment Management Inc. grew its holdings in shares of Olaplex by 181.6% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 24,500,600 shares of the company’s stock valued at $42,387,000 after buying an additional 15,800,642 shares during the last quarter. Boston Partners grew its stake in Olaplex by 276.0% during the 4th quarter. Boston Partners now owns 6,674,169 shares of the company’s stock valued at $11,257,000 after purchasing an additional 4,899,171 shares during the last quarter. Ninety One UK Ltd increased its holdings in shares of Olaplex by 99.3% in the fourth quarter. Ninety One UK Ltd now owns 4,239,796 shares of the company’s stock valued at $7,335,000 after purchasing an additional 2,112,009 shares during the period. Geode Capital Management LLC raised its stake in shares of Olaplex by 14.5% in the third quarter. Geode Capital Management LLC now owns 3,708,821 shares of the company’s stock worth $8,717,000 after purchasing an additional 468,570 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its holdings in shares of Olaplex by 9.6% during the fourth quarter. Renaissance Technologies LLC now owns 3,076,969 shares of the company’s stock worth $5,323,000 after purchasing an additional 268,969 shares during the period. Institutional investors and hedge funds own 87.37% of the company’s stock.
Olaplex Company Profile
Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.
Featured Stories
- Five stocks we like better than Olaplex
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- Stock Market Upgrades: What Are They?
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- Market Cap Calculator: How to Calculate Market Cap
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.